An observational study on bloodstream extended-spectrum beta-lactamase infection in critical care unit: Incidence, risk factors and its impact on outcome

References

Page 1

	Year	Citations
Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study Kanimozhi Kumarasamy, Mark A. Toleman, Timothy R. Walsh, The Lancet Infectious Diseases Antimicrobial Resistance GeneAntimicrobial SusceptibilityHealth SciencesAntibioticsEpidemiological Study	2010	2.9K
Antibiotic Therapy for Klebsiella pneumoniae Bacteremia: Implications of Production of Extended-Spectrum -Lactamases David L. Paterson, Wen‐Chien Ko, Anne von Gottberg, Clinical Infectious Diseases Klebsiella PneumoniaeKlebsiella Pneumoniae BacteremiaLatin AmericaExtended-spectrum -LactamasesDrug Resistance	2004	559
Ceftazidime-Resistant Klebsiella pneumoniae and Escherichia coli Bloodstream Infection: A Case-Control and Molecular Epidemiologic Investigation Deborah A. Schiappa, Mary K. Hayden, Marian Matushek, The Journal of Infectious Diseases Bloodstream InfectionAntimicrobial SusceptibilityMolecular Epidemiologic InvestigationAntibioticsHealth Sciences	1996	252
Emergence of High Levels of Extended-Spectrum-β-Lactamase-Producing Gram-Negative Bacilli in the Asia-Pacific Region: Data from the Study for Monitoring Antimicrobial Resistance Trends (SMART) Program, 2007 Stephen Hawser, Samuel K. Bouchillon, Daryl J. Hoban, Antimicrobial Agents and Chemotherapy Klebsiella PneumoniaeAsia-pacific RegionEscherichia ColiAntimicrobial ChemotherapyAntibiotic Resistance	2009	222
Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: risk factors and clinical outcome Bin Du, Yun Long, Hongzhong Liu, Intensive Care Medicine Medical MicrobiologyAntimicrobial SusceptibilityHealth SciencesAntibioticsKlebsiella Pneumoniae	2002	208
New Delhi Metallo-beta lactamase (NDM-1) in Enterobacteriaceae: treatment options with carbapenems compromised. Payal Deshpande, Camilla Rodrigues, Anjali Shetty, PubMed	2010	197
Risk Factors for Colonization with Extended-Spectrum β-Lactamase–producing Bacteria and Intensive Care Unit Admission Anthony D. Harris, Jessina C. McGregor, Judith A. Johnson, Emerging infectious diseases Pathogenic MicrobiologyKlebsiella PneumoniaeBacterial PathogensIntensive Care UnitExtended-spectrum β-Lactamase–producing Bacteria	2007	174
Regional variation in the prevalence of extended-spectrum β-lactamase–producing clinical isolates in the Asia-Pacific region (SENTRY 1998–2002) Yoichi Hirakata, Junichi Matsuda, Yoshitsugu Miyazaki, Diagnostic Microbiology and Infectious Disease Regional VariationAntibioticsKlebsiella PneumoniaeAsia-pacific RegionSentry 1998–2002	2005	155
Molecular Correlation for the Treatment Outcomes in Bloodstream Infections Caused by<i>Escherichia coli</i>and<i>Klebsiella pneumoniae</i>with Reduced Susceptibility to Ceftazidime Annie Wong‐Beringer, Janet A. Hindler, Michael J. Loeloff, Clinical Infectious Diseases Microbial PathogensMolecular CorrelationKlebsiella PneumoniaeEscherichia ColiBacterial Pathogens	2002	126
Clinical implications of extended-spectrum β-lactamase-producing Klebsiella pneumoniae bacteraemia Baek-Nam Kim, J.-H Woo, M.-N Kim, Journal of Hospital Infection Clinical ImplicationsAntimicrobial SusceptibilityAntibioticsKlebsiella PneumoniaeMicrobiology	2002	114

Page 1